JACQUELINE POLACH: Open Payments
NPI 1760733208 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 15 payments from 7 companies in 2025. Trend: 2023 $211 · 2024 $409 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $69 |
| LEO Pharma Inc. | 3 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| Incyte Corporation | 2 | $49 |
| Galderma Laboratories, L.P. | 2 | $41 |
| ABBVIE INC. | 2 | $27 |
| Janssen Biotech, Inc. | 1 | $21 |
Products named: OTEZLA, ADBRY, COSENTYX, OPZELURA, NEMLUVIO, SKYRIZI, TREMFYA.
Industry payments across CA — which companies pay providers there.
